HEPION PHARMACEUTICALS, INC. Operating Leases, Rent Expense
HEPION PHARMACEUTICALS, INC. (HEPA) reported Operating Leases, Rent Expense of $61.00 thousand for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2019-05-15
- HEPION PHARMACEUTICALS, INC. operating leases, rent expense for the quarter ending 2019-03-31 was $61.00K, a 26.51% decline year-over-year.
- HEPION PHARMACEUTICALS, INC. operating leases, rent expense for the quarter ending 2018-03-31 was $83.00K.
- HEPION PHARMACEUTICALS, INC. operating leases, rent expense for fiscal 2018 was $289.50K.
- HEPION PHARMACEUTICALS, INC. operating leases, rent expense for fiscal 2017 was $183.72K, a 31.42% increase from fiscal 2016.
- HEPION PHARMACEUTICALS, INC. operating leases, rent expense for fiscal 2016 was $139.80K, a 16.74% increase from fiscal 2015.
- HEPION PHARMACEUTICALS, INC. operating leases, rent expense for fiscal 2015 was $119.75K, a 1030.76% increase from fiscal 2014.
| Period end | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 6 month | Operating Leases, Rent Expense 12 month |
|---|---|---|---|
| 2019-03-31 | $61.00K 10-Q · filed 2019-05-15 | ||
| 2018-12-31 | $289.50K 10-K · filed 2019-03-14 | ||
| 2018-03-31 | $83.00K 10-Q · filed 2019-05-15 | ||
| 2017-12-31 | $101.73K 10-K · filed 2019-03-14 | ||
| 2017-06-30 | $183.72K 10-K · filed 2019-03-14 | ||
| 2016-06-30 | $139.80K 10-KT · filed 2018-03-26 | ||
| 2015-06-30 | $119.75K 10-K · filed 2016-09-28 | ||
| 2014-06-30 | $10.59K 10-K · filed 2015-09-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |